Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Waxman Underscores Firm Stance On Creating Public Insurance Plan In Health Reform Bill

This article was originally published in The Pink Sheet Daily

Executive Summary

House Commerce Committee Chairman Waxman dismisses idea of cooperative insurance as an alternative.

You may also be interested in...



House Reform Bill Gives HHS Rx Price Negotiating Power Through Public Plan

Democrats have found a vehicle for giving the government the ability to directly negotiate drug prices with manufacturers: the public health insurance plan envisioned in the draft reform bill by three House committees

“Co-op Insurance” Emerges As Alternative To Health Reform Public Plan, But What Is It?

Republicans are reportedly open to providing a cooperative insurance plan as an alternative to a public plan as part of the expansion of health care coverage.

GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds

New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.

Topics

UsernamePublicRestriction

Register

PS069803

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel